|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Prepaid expenses and other current assets | ||||
| Total current assets | ||||
| Right-of-use asset | ||||
| Intangible assets, net | ||||
| Deferred offering cost | ||||
| Security deposit | ||||
| TOTAL ASSETS | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable and accrued expenses | ||||
| Derivative liability instrument | ||||
| Current portion of operating lease liability | ||||
| Total current liabilities | ||||
| Operating lease liability, net of current portion | ||||
| Long-term debt, net | ||||
| Deferred revenue | ||||
| TOTAL LIABILITIES | ||||
| STOCKHOLDERS’ EQUITY | ||||
| Common Stock, $0.0001 par value, 500 million shares authorized at June 30, 2026 and December 31, 2025; 29,788,040 and 29,445,183 shares issued at June 30, 2026 and December 31, 2025, respectively | ||||
| Additional paid-in capital | ||||
| Subscription receivable | ||||
| Accumulated deficit | ||||
| Total stockholders’ equity | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
